{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:35:11Z","timestamp":1782387311466,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Typically, myeloma cells express a monoclonal immunoglobulin (Ig), either heavy or light chain. Here, we present a case of multiple myeloma with clonal dual expression of kappa and lambda light chain in a 74-year-old woman. Awareness of rare biphenotypic myeloma is important for proper diagnostic workup. A 74-year-old woman underwent hip replacement with an incidental finding of 20% plasma cells in the femoral head. Subsequent bone marrow biopsy also showed about 30% of plasma cells negative for CD20, CD56, and CD117. Immunohistochemistry (IHC) and in situ hybridization studies showed a mixture of kappa and lambda plasma cells. Flow cytometry showed ambiguous results for cytoplasmic Ig light chains kappa and lambda. However, cyclin D1 was highly expressed by plasma cells, and increased free kappa light chains were identified in serum. Further investigation by double IHC demonstrated co-expression of kappa and lambda light chains in the same cells. Fluoresces in situ hybridization studies were positive for t(11;14)(q13;q32) and the deletion 13q. Since its first description by Taylor and Burns in 1974, the demonstration of restricted cytoplasmic Ig light chain expression by immunohistochemistry is 1 of the basic tools for corroborating clonality of the plasma cells in tissue biopsy. IHC results in myeloma with dual expression of Ig light chains may suggest polyclonal plasma cell population, especially when plasma cells do not form sheets in the bone marrow. In an appropriate clinical setting, other investigations are needed to exclude plasma cell neoplasm, even with seemingly \u201cpolytypic\u201d results by IHC.<\/jats:p>","DOI":"10.1097\/pai.0000000000001069","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T12:00:10Z","timestamp":1667217610000},"page":"447-451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Dual Expression of Immunoglobulin Light Chains in Plasma Cell Myeloma: A Case Report and Literature Review"],"prefix":"10.1097","volume":"31","author":[{"given":"Janarthanee","family":"Suresh","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan"},{"name":"Saskatchewan Health Authority, Saskatoon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathi","family":"Sabaratnam","sequence":"additional","affiliation":[{"name":"Saskatchewan Health Authority, Saskatoon"},{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Brijlall","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"Department of Orthopedic, Victoria Hospital, Prince Albert Parkland Health Region, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Kyle","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan"},{"name":"Saskatchewan Health Authority, Saskatoon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina E.","family":"Torlakovic","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan"},{"name":"Saskatchewan Health Authority, Saskatoon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-85772-3_2","article-title":"Epidemiology of multiple myeloma","volume":"183","author":"Becker","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2018.12.001","article-title":"Laboratory assessment of multiple myeloma","volume":"89","author":"Morrison","year":"2019","journal-title":"Adv Clin Chem"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-065X.2010.00940.x","article-title":"Plasma cell development and survival","volume":"237","author":"Oracki","year":"2010","journal-title":"Immunol Rev"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.imlet.2017.06.006","article-title":"The discovery of plasma cells: An historical note","volume":"188","author":"Ribatti","year":"2017","journal-title":"Immunol Lett"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jtct.2021.05.027","article-title":"The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma","volume":"27","author":"Holstein","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.20512","article-title":"Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders","volume":"78","author":"Paiva","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1038\/bcj.2017.90","article-title":"Current applications of multiparameter flow cytometry in plasma cell disorders","volume":"7","author":"Jelinek","year":"2017","journal-title":"Blood Cancer J"},{"key":"R12-20250525","first-page":"889","article-title":"M components-a review of 1242 cases","volume":"114","author":"Ameis","year":"1976","journal-title":"Can Med Assoc J"},{"key":"R13-20250525","first-page":"BD03","article-title":"A rare case of multiple myeloma with biclonal gammopathy","volume":"10","author":"Banerjee","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R14-20250525","first-page":"593","article-title":"Immunoglobulin heavy and light chain isotypes in multiple myeloma patients","volume":"8","author":"Ansari","year":"2007","journal-title":"Asian Pac J Cancer Prev"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","article-title":"The clinical aspects of biclonal gammopathies. Review of 57 cases","volume":"71","author":"Kyle","year":"1981","journal-title":"Am J Med"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5858\/2006-130-853-DSILEI","article-title":"Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders","volume":"130","author":"Xu","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20250525","first-page":"4718","article-title":"Plasma cell myeloma with dual expression of kappa and lambda light chains","volume":"11","author":"Jiang","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"R18-20250525","first-page":"2224","article-title":"Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia","volume":"6","author":"Gentry","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R19-20250525","first-page":"8536","article-title":"Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains","volume":"8","author":"Jiwani","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2019-01-898171","article-title":"Biphenotypic plasma cell myeloma","volume":"133","author":"Kurt","year":"2019","journal-title":"Blood"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative {kappa} and {lambda} free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin Chem"},{"key":"R23-20250525","first-page":"812","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","journal-title":"Blood 2005"},{"key":"R24-20250525","first-page":"e3148","article-title":"An overview of light chain multiple myeloma: clinical characteristics and rarities, management strategies, and disease monitoring","volume":"10","author":"Rafae","year":"2018","journal-title":"Cureus"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ijlh.12882","article-title":"Recent advances in cytogenetic characterization of multiple myeloma","volume":"41","author":"Saxe","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jcp.27.1.14","article-title":"The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labeled antibody","volume":"27","author":"Taylor","year":"1974","journal-title":"J Clin Pathol"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000001069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T19:02:00Z","timestamp":1748199720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000001069","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"2021-10-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}